查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1875982

單細胞分析全球市場

Single-Cell Analysis
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球單細胞分析市場預計到2030年將達到280億美元

全球單細胞分析市場規模在2024年估計為101億美元，預計到2030年將達到280億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為18.6%。本報告分析的細分市場之一—腫瘤學應用，預計將以20.5%的複合年成長率成長，並在分析期結束時達到111億美元。免疫學應用預計在分析期內將以19.4%的複合年成長率成長。

美國市場規模估計為27億美元，而中國市場預計將以17.1%的複合年成長率成長。

預計到2024年，美國單細胞分析市場規模將達27億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到41億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）將達到17.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到17.1%和15.6%。在歐洲，德國的複合年成長率預計將達到約13.0%。

全球單細胞分析市場—主要趨勢與促進因素摘要

為什麼單細胞分析在生物醫學研究中變得至關重要？

單細胞分析已成為生物醫學研究的關鍵技術，因為它能夠提供極其詳盡的細胞異質性訊息，使研究人員能夠以前所未有的深度理解複雜的生物系統。與提供細胞群體平均數據的群體細胞分析不同，單細胞分析能夠研究單一細胞，揭示其獨特的細胞狀態和功能。這種能力在腫瘤學、免疫學和發育生物學等領域至關重要，因為在這些領域，理解細胞多樣性和行為是闡明疾病機制、發現生物標記和開發標靶治療的關鍵。因此，單細胞分析正日益應用於學術研究、藥物開發和臨床診斷，以推進精準醫療並改善患者預後。

技術進步如何提高單細胞分析的能力？

技術進步顯著提升了單細胞分析的能力，提高了資料收集和解讀的準確性、通量和可及性。基於高通量單細胞RNA定序（scRNA-seq）、質譜流式細胞儀和微流體技術的平台開發，實現了對數千個單細胞的同步分析，從而能夠全面深入了解細胞異質性。此外，整合基因組學、轉錄組學、蛋白質組學和代謝體學資料的多體學方法創新，拓展了單細胞分析的範圍，使其不再局限於RNA表現。人工智慧（AI）和機器學習（ML）在資料分析和解讀中的應用，也簡化了從複雜資料集中提取有效資訊的過程。這些進步使單細胞分析更加穩健、擴充性且易於使用，促進了其在各種研究和臨床環境中的應用。

哪些細分市場正在推動單細胞分析技術的應用？

單細胞分析技術包括耗材（試劑、試劑盒、儀器）及設備（流式細胞儀、質譜儀、定序平台）。單細胞分析的應用領域涵蓋癌症研究、免疫學、神經學、幹細胞研究和發育生物學，其中癌症研究和免疫學領域由於對腫瘤微環境和免疫細胞譜分析的迫切需求，成為市場的主要驅動力。終端用戶包括學術研究機構、製藥和生物技術公司、醫院和診斷實驗室，其中專注於基礎研究和轉化研究的學術研究機構佔據了大部分應用。從區域來看，北美和歐洲是最大的單細胞分析市場，這主要得益於雄厚的研究經費、先進的醫療基礎設施以及眾多生物技術Start-Ups公司。同時，亞太地區正崛起為高成長地區，這主要得益於不斷擴大的生物醫學研究活動和日益成長的醫療保健投資。

推動單細胞分析市場成長的關鍵因素有哪些？

單細胞分析市場的成長受多種因素驅動，包括對精準醫療和標靶治療日益成長的需求、高通量和多組體學單細胞平台的技術進步，以及單細胞分析在癌症研究、免疫學和神經病學領域應用的不斷擴展。使用者友好、自動化和擴充性的單細胞分析系統的開發正在推動學術研究人員、製藥公司和臨床實驗室對該市場的接受度。人工智慧和機器學習在高效數據分析、解讀和視覺化方面的應用，正在推動市場在各個終端用戶領域的擴張。單細胞分析在藥物發現、生物標記開發和個人化治療策略的應用日益廣泛，加上對創新、經濟高效且高精度工具的需求，為市場成長創造了新的機會。此外，對非侵入性、無標定和高解析度單細胞分析方法的研發投入不斷增加，也進一步推動了市場擴張。

部分：

按應用領域（腫瘤學、免疫學、幹細胞、非侵入性產前診斷、神經病學、其他應用）；按應用領域（學術和研究實驗室、生物技術和製藥公司、醫院和診斷實驗室、其他應用）

受訪公司範例

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP14756

Global Single-Cell Analysis Market to Reach US$28.0 Billion by 2030

The global market for Single-Cell Analysis estimated at US$10.1 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. Cancer Application, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Immunology Application segment is estimated at 19.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 17.1% CAGR

The Single-Cell Analysis market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 17.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Single-Cell Analysis Market - Key Trends and Drivers Summarized

Why Is Single-Cell Analysis Becoming Indispensable in Biomedical Research?

Single-cell analysis has become indispensable in biomedical research due to its ability to provide highly detailed insights into cellular heterogeneity, allowing researchers to understand complex biological systems at an unprecedented level. Unlike bulk cell analysis, which offers averaged data across a population of cells, single-cell analysis enables the examination of individual cells, revealing unique cellular states and functions. This capability is crucial for fields such as oncology, immunology, and developmental biology, where understanding cellular diversity and behavior is key to identifying disease mechanisms, discovering biomarkers, and developing targeted therapies. As a result, single-cell analysis is increasingly being adopted in academic research, pharmaceutical development, and clinical diagnostics to advance precision medicine and improve patient outcomes.

How Are Technological Advancements Enhancing the Capabilities of Single-Cell Analysis?

Technological advancements are significantly enhancing the capabilities of single-cell analysis by improving the accuracy, throughput, and accessibility of data collection and interpretation. The development of high-throughput single-cell RNA sequencing (scRNA-seq), mass cytometry, and microfluidics-based platforms has enabled the simultaneous analysis of thousands of individual cells, providing a comprehensive view of cellular heterogeneity. Moreover, innovations in multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics data, are expanding the scope of single-cell analysis beyond just RNA expression. The integration of artificial intelligence (AI) and machine learning (ML) for data analysis and interpretation is also streamlining the extraction of meaningful insights from complex datasets. These advancements are making single-cell analysis more robust, scalable, and user-friendly, thereby driving its adoption across various research and clinical settings.

Which Market Segments Are Leading the Adoption of Single-Cell Analysis?

Types of single-cell analysis technologies include consumables (reagents, kits, and instruments) and instruments (flow cytometers, mass spectrometers, and sequencing platforms). Applications of single-cell analysis span cancer research, immunology, neurology, stem cell research, and developmental biology, with cancer research and immunology leading the market due to the high demand for understanding tumor microenvironments and immune cell profiling. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories, with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for single-cell analysis due to strong research funding, advanced healthcare infrastructure, and a high number of biotech startups, while Asia-Pacific is emerging as a high-growth region driven by expanding biomedical research activities and increasing healthcare investments.

What Are the Key Drivers of Growth in the Single-Cell Analysis Market?

The growth in the single-cell analysis market is driven by several factors, including the rising demand for precision medicine and targeted therapies, technological advancements in high-throughput and multi-omics single-cell platforms, and the increasing use of single-cell analysis in cancer research, immunology, and neurology. The development of user-friendly, automated, and scalable single-cell analysis systems is driving market adoption among academic researchers, pharmaceutical companies, and clinical laboratories. The focus on integrating AI and machine learning for efficient data analysis, interpretation, and visualization is expanding the market reach among diverse end-users. The growing use of single-cell analysis in drug discovery, biomarker development, and personalized treatment strategies, coupled with the demand for innovative, cost-effective, and high-precision tools, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for non-invasive, label-free, and high-resolution single-cell analysis methods are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Single-Cell Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology, Other Applications); End-Use (Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Single-Cell Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine and Targeted Therapies Spurs Single-Cell Analysis Market Growth
    • Technological Advancements in Genomics, Transcriptomics, and Proteomics Strengthen the Business Case for Single-Cell Analysis
    • Increasing Adoption of Single-Cell Analysis in Cancer Research Expands Addressable Market Opportunity
    • Development of High-Throughput and High-Resolution Single-Cell Analysis Platforms Drives Adoption
    • Growing Focus on Understanding Cellular Heterogeneity and Immune System Dynamics Generates New Market Opportunities
    • Integration of Artificial Intelligence and Machine Learning in Data Analysis Throws Spotlight on Single-Cell Analysis Market Potential
    • Expansion of Single-Cell Analysis Applications in Neurology, Immunology, and Developmental Biology Creates New Growth Avenues
    • Development of User-Friendly, Automated, and Multi-Omics Single-Cell Platforms Reinforces Market Adoption
    • Growing Demand for Single-Cell Sequencing in Drug Discovery and Development Sustains Market Growth
    • Focus on Developing Non-Invasive, Label-Free, and High-Precision Single-Cell Analysis Methods Drives Innovation
    • Rising Adoption of Single-Cell Analysis in Clinical Diagnostics and Biomarker Discovery Spurs Market Demand
    • Shift Towards Single-Cell Multi-Omics and Spatial Transcriptomics Strengthens Market Competitiveness
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Single-Cell Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Non-Invasive Prenatal Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Academic & Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION